Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bull 3X Shares Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$115.43 |
52 Week High | US$176.99 |
52 Week Low | US$48.40 |
Beta | 0 |
11 Month Change | 12.40% |
3 Month Change | -12.84% |
1 Year Change | -1.68% |
33 Year Change | -92.22% |
5 Year Change | -88.43% |
Change since IPO | -96.48% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
LABU | US Capital Markets | US Market | |
---|---|---|---|
7D | 11.8% | 1.0% | -0.5% |
1Y | -1.7% | 32.5% | 24.2% |
Return vs Industry: LABU underperformed the US Capital Markets industry which returned 32.5% over the past year.
Return vs Market: LABU underperformed the US Market which returned 24.2% over the past year.
Price Volatility
LABU volatility | |
---|---|
LABU Average Weekly Movement | 10.9% |
Capital Markets Industry Average Movement | 3.5% |
Market Average Movement | 5.7% |
10% most volatile stocks in US Market | 15.5% |
10% least volatile stocks in US Market | 2.9% |
Stable Share Price: LABU's share price has been volatile over the past 3 months.
Volatility Over Time: LABU's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2015 | n/a | n/a | www.direxion.com/product/daily-sp-biotech-bull-bear-3x-etfs |
Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bull 3X Shares is an exchange traded fund launched by Direxion Investments. It is managed by Rafferty Asset Management, LLC. It invests in public equity markets of the United States.
Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bull 3X Shares Fundamentals Summary
LABU fundamental statistics | |
---|---|
Market cap | US$1.12b |
Earnings (TTM) | US$0 |
Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs LABU overvalued?
See Fair Value and valuation analysisEarnings & Revenue
LABU income statement (TTM) | |
---|---|
Revenue | US$0 |
Cost of Revenue | US$0 |
Gross Profit | US$0 |
Other Expenses | US$0 |
Earnings | US$0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did LABU perform over the long term?
See historical performance and comparison